Evidence map›Paper›PMID 29038350›Full record

ArticlePhysiological reports2017

Male apoE*3-Leiden.CETP mice on high-fat high-cholesterol diet exhibit a biphasic dyslipidemic response, mimicking the changes in plasma lipids observed through life in men.

Yared Paalvast, Albert Gerding, Yanan Wang, Vincent W Bloks, Theo H van Dijk, Rick Havinga, Ko Willems van Dijk, Patrick C N Rensen, Barbara M Bakker, Jan Albert Kuivenhoven and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Physiological reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Animal models of human atherosclerosis: current progress.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Review
  11. Article
  12. Article
  13. Modelling of atherosclerosis in genetically modified animals.American journal of translational research · 2019
    Review
  14. Mouse Models for Atherosclerosis Research-Which Is My Line?Frontiers in cardiovascular medicine · 2019
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yared PaalvastDepartment of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands y.paalvast@umcg.nl.
Albert GerdingDepartment of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands.
Yanan WangDepartment of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands.
Vincent W BloksDepartment of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands.
Theo H van DijkDepartment of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands.
Rick HavingaDepartment of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands.
Ko Willems van DijkDepartment Medicine, Division Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Patrick C N RensenDepartment Medicine, Division Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.
Barbara M BakkerDepartment of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands.
Jan Albert KuivenhovenDepartment of Pediatrics, University Medical Center Groningen, Groningen, The Netherlands.
Albert K GroenDepartment of Laboratory Medicine, University Medical Center Groningen, Groningen, The Netherlands.
University Medical Center Groningen · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Physiological adaptations resulting in the development of the metabolic syndrome in man occur over a time span of several decades. This combined with the prohibitive financial cost and ethical concerns to measure key metabolic parameters repeatedly in subjects for the major part of their life span makes that comprehensive longitudinal human data sets are virtually nonexistent. While experimental mice are often used, little is known whether this species is in fact an adequate model to better understand the mechanisms that drive the metabolic syndrome in man. We took up the challenge to study the response of male apoE*3-Leiden.CETP mice (with a humanized lipid profile) to a high-fat high-cholesterol diet for 6 months. Study parameters include body weight, food intake, plasma and liver lipids, hepatic transcriptome, VLDL - triglyceride production and importantly the use of stable isotopes to measure hepatic de novo lipogenesis, gluconeogenesis, and biliary/fecal sterol secretion to assess metabolic fluxes. The key observations include (1) high inter-individual variation; (2) a largely unaffected hepatic transcriptome at 2, 3, and 6 months; (3) a biphasic response curve of the main metabolic features over time; and (4) maximum insulin resistance preceding dyslipidemia. The biphasic response in plasma triglyceride and total cholesterol appears to mimic that of men in cross-sectional studies. Combined, these observations suggest that studies such as these can help to delineate the causes of metabolic derangements in patients suffering from metabolic syndrome.

Indexed as

AnimalsApolipoprotein E3CholesterolDiet, High-FatDyslipidemiasHumansInsulin ResistanceLipid MetabolismLipidsLiverMaleMiceApolipoprotein E3apolipoprotein E3 (Leidein)CholesterolLipidsBiphasicdyslipidemiainsulin resistancemetabolic syndrome

Identifiers

PMID29038350
PMCPMC5641925
OpenAlexW2765698422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.